Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Common Stock | Options Exercise | $76.2K | +20K | +537.49% | $3.81 | 23.7K | Sep 1, 2021 | Direct | F1 |
transaction | DVAX | Common Stock | Sale | -$400K | -20K | -84.31% | $20.00 | 3.72K | Sep 1, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Stock Option (Right to Buy) | Options Exercise | -20K | -100% | 0 | Sep 1, 2021 | Common Stock | 20K | $3.81 | Direct | F1, F3, F4 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2021. |
F2 | All shares were sold at $20.00. |
F3 | All of the shares subject to the option vested and become fully-exercisable on August 13, 2020. |
F4 | Not applicable. |